Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Walsh, B. T. Articles by Parides, M. K. Search for Related Content PubMed Citation Articles by Walsh, B. T. Articles by Parides, M. K. Eating Disorders Other Psychotherapy Antidepressants

Treatment of Bulimia Nervosa in a Primary Care Setting

OBJECTIVE: The authors’ goal was to determine whether treatments known to be effective for bulimia nervosa in specialized treatment centers can be used successfully in primary health care settings. They examined the benefits of two treatments for bulimia: 1) fluoxetine, an antidepressant medication, and 2) guided self-help, an adaptation of cognitive behavior therapy. METHOD: Ninety-one female patients in two primary care settings were randomly assigned to receive fluoxetine alone, placebo alone, fluoxetine plus guided self-help, or placebo and guided self-help. RESULTS: The majority of the patients did not complete the treatment trial; many patients found the treatment program too demanding, but others indicated it was not sufficiently intensive. Patients assigned to fluoxetine attended more physician visits, exhibited a greater reduction in binge eating and vomiting, and had a greater improvement in psychological symptoms than those assigned to placebo. There was no evidence of benefit from guided self-help. CONCLUSIONS: The treatment of patients with bulimia nervosa in a primary care setting is hampered by a high dropout rate. Guided self-help, a psychological treatment based on cognitive behavior therapy, appears ineffective, but treatment with fluoxetine is associated with better retention and substantial symptomatic improvement.

This article has been cited by other articles:

				G. C. Patton, C. Coffey, J. B. Carlin, L. Sanci, and S. Sawyer Prognosis of adolescent partial syndromes of eating disorder The British Journal of Psychiatry, April 1, 2008; 192(4): 294 - 299. [Abstract] [Full Text] [PDF]

				E. Hazen and M. Fava Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report J Psychopharmacol, September 1, 2006; 20(5): 723 - 724. [Abstract] [PDF]

				J. Yager, M. J. Devlin, K. A. Halmi, D. B. Herzog, J. E. Mitchell, P. S. Powers, and K. J. Zerbe Eating Disorders Focus, October 1, 2005; 3(4): 503 - 510. [Abstract] [Full Text] [PDF]

				J. Yager, M. J. Devlin, K. A. Halmi, D. B. Herzog, J. E. Mitchell, P. S. Powers, and K. J. Zerbe Guideline Watch: Practice Guideline for the Treatment of Patients With Eating Disorders, 2nd Edition Focus, October 1, 2005; 3(4): 546 - 551. [Full Text] [PDF]

				J. Rosack Med Check Psychiatr News, May 21, 2004; 39(10): 37 - 37. [Full Text]

				Minerva BMJ, March 13, 2004; 328(7440): 652 - 652. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us